Medipal HoldingsMAHLY +5.92%78 Days Payable is 114.12 as of Mar. 2026, which is 7% above its 10-year median of 106.72. GuruFocus rates MAHLY with a GF Score™ of 78/100 and a GF Value™ of $16.37 (Fairly Valued). The stock has 1 warning sign investors should review. Among 115 Medical Distribution companies, Medipal Holdings ranks better than 66.09% on this metric.
The historical rank and industry rank for Medipal Holdings's Days Payable or its related term are showing as below:
MAHLY'
s Days Payable Range Over the Past 10 Years
Min: 98.37 Med: 106.72 Max: 110.6
Current: 102.5
During the past 13 years, Medipal Holdings's highest Days Payable was 110.60. The lowest was 98.37. And the median was 106.72.
MAHLY's Days Payable is ranked better than 66.09% of 115
companies
in the Medical Distribution industry
Industry Median: 79.81
vs MAHLY: 102.50
Medipal Holdings's Days Payable
increased
from Mar. 2025 (111.80) to Mar. 2026 (114.12).
It may suggest that Medipal Holdingsdelayed paying its suppliers.
Medipal Holdings Days Payable Related Terms
Medipal Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Medipal Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medipal Holdings's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (MAHLY) has a Days Payable of 114.12 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medipal Holdings and its competitors. This is near median its historical median of 106.72. Over the past decade, Medipal Holdings' Days Payable has ranged from 98.37 to 110.60. According to the industry distribution chart, Medipal Holdings ranks #39 out of 115 companies in the Medical Distribution industry, placing it in the top 33.9%.
Is Medipal Holdings' Days Payable too high?
Medipal Holdings' current Days Payable of 114.12 is near median its 10-year median of 106.72. Over the past 10 years, this metric has ranged from a low of 98.37 to a high of 110.60. The Medical Distribution industry median Days Payable is 79.81. Medipal Holdings' value of 114.12 is 43% above this industry median. Based on the distribution chart, Medipal Holdings ranks #39 out of 115 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #39 out of 115 companies for Days Payable. This puts Medipal Holdings in the upper half of its industry. The industry median Days Payable is 79.81. Medipal Holdings' value of 114.12 is 43% above this benchmark. Historically, Medipal Holdings' own Days Payable has ranged from 98.37 to 110.60 over the past decade. While the company's 10-year median is 106.72 vs. the industry median of 79.81, Medipal Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.81, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current Days Payable of 114.12 is 43% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median Days Payable is 79.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current Days Payable is 114.12, which is near median its own 10-year median of 106.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.37, compared to a current price of $16.28 — trading 0.5% below its estimated fair value. The current Days Payable is 114.12, which is near median its 10-year median of 106.72 and 43% above the Medical Distribution industry median of 79.81. Medipal Holdings' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Days Payable is 114.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MAHLY) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be undervalued.
The current stock price of $16.28 is trading 0.5% below its estimated GF Value™ of $16.37.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MAHLY:
Days Payable: 114.12 (near median its 10-year median of 106.72)
GF Value™: $16.37 vs. price of $16.28 (0.5% below fair value)
Industry Position: 43% above the Medical Distribution median (#39 of 115)
No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
78GF Score
Get the complete analysis for MAHLY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAHLY has been successfully added to your 
